Life Science Leader - Home Page
WEBVolastra Therapeutics is a drug discovery and development leader in the emerging field of chromosomal instability, a phenomenon that can determine how certain solid tumor cancer cells replicate and grow. OSE Immunotherapeutics is poised to begin a confirmatory and pivotal Phase 3 trial for a novel cancer vaccine targeting the second line in ...
Ahead Of The Curve On Radiopharmaceuticals - Life Science Leader
WEBJan 1, 2024 — Despite the negatives – a complicated supply chain, short half-life, and the radioactive fear factor – analysts are forecasting continued growth in radiopharmaceuticals (from approximately $5-7 billion in 2022 to $9-$13 billion in 2032), amid a shift in focus from diagnostics to therapeutics. In late December, Bristol Myers Squibb announced ...
Gaurav Shah — A Rare Disease Biopharma CEO Shares A Rare …
WEBFeb 6, 2020 — Gaurav Shah, M.D., is the CEO of Rocket Pharmaceuticals, a publicly traded (NASDAQ: RCKT) biopharmaceutical company. “We’re a relatively new company, about four years old, with four programs already in the clinic and another on the way,” he says. Being a platform agnostic gene therapy company, Rocket’s …
Digital Technologies Will Continue To Drive Patient Outcomes
WEBJun 1, 2021 — <p>While other companies scrambled to implement clinical trial-related technology to deal with the pandemic, Otsuka was an early adopter of tools such as eCRF and eConsent. Christoph Koenen, EVP and chief medical officer at Otsuka Pharmaceutical Companies (U.S.) explains how digital technologies will continue to drive patient outcomes.</p>
Vincerx Pharma: Finding Strength In Symbiosis
WEBAug 1, 2023 — Vincerx Pharma: Finding Strength In Symbiosis. By Ben Comer, Chief Editor, Life Science Leader. Biotech is not a business for the faint of heart, the easily discouraged, or the overly sensitive, facts to which Vincerx CEO and Board Chairman Ahmed Hamdy, MD, and COO and President Raquel Izumi, Ph.D., can readily attest. “Steel sharpens steel ...
An Interview with Robert Hariri MD PhD CEO and founder of …
WEBJan 28, 2020 — At the 2019 CNS Summit, Life Science Leader’s chief editor, Rob Wright, had the opportunity to interview Robert (Bob) Hariri, M.D., Ph.D., CEO and founder of Celularity. Though Hariri was featured in August (How Serial Entrepreneur Robert Hariri Is Revolutionizing Cell Therapy), and the subject of a number of …
Merck's Continuous Process Improvement - Life Science Leader
WEBJul 1, 2014 — Merck embraced a process of continuous improvement after years of implementing Lean initiatives that yielded periodic improvements. With Lean, Six Sigma, Kaizen, Agile, total quality management, and other process improvement approaches, after an initial surge, results sometimes slipped backwards to baseline levels.
FSP Or Full-Service Outsourcing For Clinical Trials? - Life Science …
WEBDec 3, 2013 — Functional service provider (FSP) partnerships have been gaining traction in recent years because of their potential to increase efficiency and flexibility in outsourcing without compromising quality. Well-defined services within the scope of a clinical trial project or program (e.g. data management, biostatistics, or medical writing) are good ...
Pharmaceutical Scientists' Salaries in 2023
WEBJan 15, 2024 — In fact, salaries were up among industry scientists as well as academic scientists (AAPS members) – mean annual base salary from principle, full-time employment in the U.S. as of June 1 (the date of the survey cut off) was $190,100, a 6.7% increase from 2022 ($178,100). Pharmaceutical scientists outside of the U.S. had average base salaries ...
Three Challenges Facing The Life Sciences Sector
WEBAug 22, 2018 — The third issue facing the life sciences sector — particularly at the time of product launch — is the need for a greater focus on the supply chain. Biologics, as compared to small molecules, have a more complex supply chain and are notably more difficult to manufacture, store, and distribute. Personalized medicine is a completely new ...